Loading...
Header Logo
Keywords
Last Name
Institution

Anne Marie Comeau

Concepts (241)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Neonatal Screening
33
2016
77
7.350
Why?
Cystic Fibrosis
15
2010
103
3.210
Why?
Infant, Newborn
43
2016
704
1.940
Why?
Severe Combined Immunodeficiency
7
2014
38
1.820
Why?
Receptors, Antigen, T-Cell
4
2014
233
1.040
Why?
Genetic Testing
6
2010
68
0.970
Why?
Genetic Diseases, Inborn
3
2015
32
0.970
Why?
Algorithms
8
2010
617
0.940
Why?
Polymerase Chain Reaction
11
2012
438
0.900
Why?
DNA Mutational Analysis
6
2010
140
0.840
Why?
Trypsinogen
5
2010
6
0.840
Why?
Cystic Fibrosis Transmembrane Conductance Regulator
5
2010
83
0.610
Why?
Program Development
3
2010
163
0.540
Why?
Health Plan Implementation
2
2010
26
0.530
Why?
Program Evaluation
5
2016
317
0.530
Why?
Massachusetts
10
2010
1468
0.520
Why?
Humans
49
2016
33464
0.520
Why?
Parents
3
2014
171
0.510
Why?
Genetic Counseling
3
2005
12
0.510
Why?
Pilot Projects
6
2014
481
0.510
Why?
HIV Infections
9
2008
639
0.500
Why?
Hematologic Tests
1
2010
11
0.500
Why?
Immunoassay
3
2010
46
0.500
Why?
DNA, Viral
4
2008
177
0.490
Why?
Immunologic Deficiency Syndromes
3
2015
74
0.430
Why?
Quality Assurance, Health Care
1
2010
228
0.420
Why?
Sweat
4
2010
4
0.400
Why?
Evidence-Based Medicine
4
2016
298
0.380
Why?
Infant
12
2016
932
0.360
Why?
T-Lymphocytes
5
2015
896
0.360
Why?
DNA
3
2010
612
0.360
Why?
Diffusion of Innovation
1
2006
50
0.350
Why?
Mutation
7
2015
1735
0.340
Why?
Professional Competence
1
2006
75
0.340
Why?
HIV Seropositivity
3
1997
73
0.340
Why?
Needs Assessment
1
2005
99
0.330
Why?
Blood Specimen Collection
5
2010
21
0.330
Why?
Advisory Committees
2
2016
31
0.330
Why?
HIV
2
1996
56
0.320
Why?
Chlorides
4
2010
35
0.310
Why?
HIV-1
7
2008
577
0.310
Why?
Predictive Value of Tests
5
2010
670
0.300
Why?
Child Health Services
1
2004
41
0.300
Why?
Communication
1
2005
271
0.290
Why?
Patient Acceptance of Health Care
1
2005
246
0.290
Why?
Primary Health Care
3
2015
381
0.290
Why?
False Positive Reactions
4
2010
57
0.280
Why?
Sensitivity and Specificity
7
2008
778
0.260
Why?
Genes, T-Cell Receptor
2
2010
8
0.250
Why?
Decision Making
3
2016
214
0.250
Why?
United States
12
2014
3926
0.240
Why?
Feasibility Studies
3
2010
249
0.220
Why?
Lymphopenia
2
2014
39
0.200
Why?
Quality Indicators, Health Care
2
2010
249
0.200
Why?
New England
2
2010
192
0.200
Why?
Sequence Analysis, DNA
2
2008
294
0.200
Why?
Practice Guidelines as Topic
3
2012
442
0.200
Why?
Mass Screening
3
2016
288
0.190
Why?
HIV Antibodies
3
1996
117
0.190
Why?
Infectious Disease Transmission, Vertical
5
2008
47
0.190
Why?
Aftercare
2
2005
19
0.180
Why?
Follow-Up Studies
3
2010
1513
0.170
Why?
Genotype
4
2008
471
0.170
Why?
Models, Organizational
2
2005
75
0.170
Why?
Guanine Nucleotide Exchange Factors
1
2015
43
0.170
Why?
Disease Management
1
2015
103
0.160
Why?
AIDS Serodiagnosis
2
1997
24
0.160
Why?
Third-Party Consent
1
2014
4
0.160
Why?
Retrospective Studies
3
2014
2480
0.150
Why?
United States Dept. of Health and Human Services
1
2013
4
0.150
Why?
Intestinal Atresia
1
2013
2
0.150
Why?
Calibration
2
2010
48
0.150
Why?
Lipids
1
2015
229
0.150
Why?
Outcome Assessment (Health Care)
2
2007
421
0.140
Why?
DNA, Circular
1
2012
5
0.140
Why?
False Negative Reactions
3
2005
30
0.140
Why?
Leukopenia
1
2012
13
0.140
Why?
Intestines
1
2013
131
0.140
Why?
Biomedical Research
1
2014
140
0.130
Why?
Point-of-Care Systems
1
2012
62
0.130
Why?
Child
4
2013
2586
0.130
Why?
alpha-Thalassemia
1
2010
3
0.130
Why?
Incidence
3
2014
768
0.130
Why?
Public Health Practice
1
2010
14
0.130
Why?
Leukodystrophy, Globoid Cell
1
2010
3
0.130
Why?
Female
11
2016
18403
0.120
Why?
Ribonucleases
1
2010
26
0.120
Why?
Health Knowledge, Attitudes, Practice
2
2005
560
0.120
Why?
Quality Control
1
2010
45
0.120
Why?
Gene Dosage
1
2010
43
0.120
Why?
Child, Preschool
5
2015
1281
0.120
Why?
Rare Diseases
1
2010
16
0.120
Why?
Cardiovascular Diseases
1
2015
550
0.120
Why?
Expert Testimony
1
2010
30
0.120
Why?
Reproducibility of Results
2
2010
961
0.120
Why?
Carrier State
1
2009
13
0.110
Why?
Oropharynx
1
2009
9
0.110
Why?
Regression Analysis
1
2010
419
0.110
Why?
Pregnancy Complications, Infectious
2
2000
47
0.110
Why?
Decision Trees
2
2005
35
0.110
Why?
Developing Countries
1
2008
51
0.110
Why?
Acyl-CoA Dehydrogenase
1
2008
7
0.110
Why?
Male
8
2015
16904
0.110
Why?
Decision Making, Organizational
2
2005
28
0.100
Why?
Intensive Care Units
1
2010
199
0.100
Why?
Proteins
1
2013
588
0.100
Why?
Time Factors
4
2005
2584
0.100
Why?
Referral and Consultation
3
2005
198
0.100
Why?
Heterozygote Detection
2
2004
16
0.100
Why?
Aging
1
1992
513
0.100
Why?
Delivery of Health Care
1
2008
152
0.090
Why?
Pseudomonas Infections
1
2006
26
0.090
Why?
Reference Standards
1
2006
44
0.090
Why?
Iontophoresis
1
2005
2
0.090
Why?
Parental Consent
1
2005
6
0.090
Why?
Physician Executives
1
2005
19
0.090
Why?
Lung Diseases
1
2006
103
0.090
Why?
Models, Psychological
1
2005
91
0.080
Why?
Clinical Protocols
1
2005
86
0.080
Why?
RNA, Viral
2
2003
198
0.080
Why?
Forecasting
1
2004
159
0.070
Why?
Virology
1
2003
11
0.070
Why?
Nucleic Acid Amplification Techniques
1
2003
17
0.070
Why?
Attitude to Health
1
2005
245
0.070
Why?
Social Support
1
2005
240
0.070
Why?
Costs and Cost Analysis
1
2003
82
0.070
Why?
Metabolism, Inborn Errors
1
2002
15
0.070
Why?
Attitude of Health Personnel
1
2005
368
0.070
Why?
Carboxylic Acids
1
2001
10
0.070
Why?
Amino Acid Metabolism, Inborn Errors
1
2001
11
0.070
Why?
Lipid Metabolism, Inborn Errors
1
2001
12
0.070
Why?
Informed Consent
1
2002
100
0.060
Why?
Zidovudine
1
2000
19
0.060
Why?
Fatty Acids
1
2001
134
0.060
Why?
B-Lymphocytes
2
2015
533
0.060
Why?
Health Policy
1
2002
128
0.060
Why?
Cohort Studies
1
2004
1363
0.060
Why?
Anti-HIV Agents
1
2000
102
0.060
Why?
Cellulose
1
1999
19
0.060
Why?
HIV Seroprevalence
1
1997
8
0.050
Why?
Risk Factors
3
2015
2937
0.050
Why?
Risk
2
2010
338
0.050
Why?
Globins
1
1996
27
0.050
Why?
Point Mutation
2
2008
145
0.050
Why?
Reference Values
2
2009
300
0.050
Why?
Blood Stains
1
1996
1
0.050
Why?
Blood Preservation
1
1996
7
0.050
Why?
National Health Programs
1
2016
11
0.050
Why?
Immunoglobulin A
1
1996
40
0.050
Why?
rac1 GTP-Binding Protein
1
2015
13
0.040
Why?
Genes, Recessive
1
2015
37
0.040
Why?
Thailand
2
2008
80
0.040
Why?
Specialization
1
2015
53
0.040
Why?
Fatal Outcome
1
2015
84
0.040
Why?
Pedigree
1
2015
152
0.040
Why?
Prospective Studies
2
1996
1600
0.040
Why?
Hematopoietic Stem Cell Transplantation
1
2015
148
0.040
Why?
Killer Cells, Natural
1
2015
188
0.040
Why?
Tissue Array Analysis
1
2013
13
0.040
Why?
Survival Analysis
1
2014
371
0.040
Why?
Consanguinity
1
2012
4
0.040
Why?
Gene Rearrangement, T-Lymphocyte
1
2012
6
0.040
Why?
Government Programs
1
2012
8
0.040
Why?
DNA Copy Number Variations
1
2012
25
0.040
Why?
Lentivirus
1
2012
29
0.040
Why?
Lymphocyte Count
1
2012
70
0.040
Why?
Adenylate Kinase
1
2012
13
0.040
Why?
Cell Line, Transformed
1
2012
88
0.040
Why?
Hearing Loss
1
2012
12
0.040
Why?
Blood
1
1992
26
0.040
Why?
Thymus Gland
1
2013
221
0.030
Why?
Professional Role
1
2012
28
0.030
Why?
Oligonucleotide Array Sequence Analysis
1
2013
268
0.030
Why?
Heart Defects, Congenital
1
2012
54
0.030
Why?
Genes, Reporter
1
2012
191
0.030
Why?
Specimen Handling
1
1992
30
0.030
Why?
Prognosis
1
2014
875
0.030
Why?
Public Health
1
2012
98
0.030
Why?
Herpesvirus 4, Human
1
2012
132
0.030
Why?
Lymphocytes
1
1992
178
0.030
Why?
Health Personnel
1
2012
140
0.030
Why?
Mass Spectrometry
2
2002
209
0.030
Why?
New York
1
2010
65
0.030
Why?
Antigens, CD45
1
2010
51
0.030
Why?
Infant, Low Birth Weight
1
2010
30
0.030
Why?
Antigens, CD3
1
2010
61
0.030
Why?
Patient Advocacy
1
2010
29
0.030
Why?
Leukocytes
1
2010
102
0.030
Why?
Leishmania
1
1989
9
0.030
Why?
RNA Viruses
1
1989
7
0.030
Why?
Gram-Negative Aerobic Rods and Cocci
1
2009
1
0.030
Why?
Gram-Positive Cocci
1
2009
2
0.030
Why?
Infant Care
1
2008
6
0.030
Why?
Genetic Vectors
1
2012
515
0.030
Why?
Infant Formula
1
2008
6
0.030
Why?
Carnitine
1
2008
15
0.030
Why?
Breast Feeding
1
2008
35
0.030
Why?
RNA, Messenger
1
2013
1248
0.030
Why?
Case-Control Studies
1
2009
636
0.020
Why?
Histidine
1
2006
27
0.020
Why?
Age of Onset
1
2006
129
0.020
Why?
Pseudomonas aeruginosa
1
2006
63
0.020
Why?
Arginine
1
2006
78
0.020
Why?
Risk Assessment
1
2010
1044
0.020
Why?
Pilocarpine
1
2005
2
0.020
Why?
Muscarinic Agonists
1
2005
7
0.020
Why?
Mutation, Missense
1
2006
115
0.020
Why?
Early Diagnosis
1
2005
43
0.020
Why?
Pregnancy
2
2000
1133
0.020
Why?
Prenatal Diagnosis
1
2004
22
0.020
Why?
Linear Models
1
2005
331
0.020
Why?
Infection Control
1
2004
36
0.020
Why?
Patient Selection
1
2005
294
0.020
Why?
Health Education
1
2004
175
0.020
Why?
Viral Load
1
2003
157
0.020
Why?
RNA Stability
1
2003
71
0.020
Why?
Age Factors
1
2005
1070
0.020
Why?
Sweating
1
2001
13
0.020
Why?
Electrolytes
1
2001
21
0.020
Why?
Mice
1
2013
7406
0.020
Why?
Heterozygote
1
2001
114
0.020
Why?
Antiviral Agents
1
2003
157
0.020
Why?
Labor, Obstetric
1
2000
21
0.020
Why?
Drug Administration Schedule
1
2000
217
0.010
Why?
Pregnancy Outcome
1
2000
97
0.010
Why?
Double-Blind Method
1
2000
453
0.010
Why?
Animals
2
2013
14740
0.010
Why?
Seroepidemiologic Studies
1
1997
17
0.010
Why?
Spain
1
1997
24
0.010
Why?
HIV-2
1
1997
22
0.010
Why?
Puerto Rico
1
1996
103
0.010
Why?
Adult
2
2000
9425
0.010
Why?
Prevalence
1
1997
759
0.010
Why?
HIV Antigens
1
1990
23
0.010
Why?
Virus Cultivation
1
1990
19
0.010
Why?
Nucleic Acid Hybridization
1
1989
90
0.010
Why?
Acquired Immunodeficiency Syndrome
1
1990
134
0.010
Why?
DNA-Directed RNA Polymerases
1
1989
44
0.010
Why?
Enzyme-Linked Immunosorbent Assay
1
1990
405
0.010
Why?
Microscopy, Electron
1
1989
259
0.010
Why?
Species Specificity
1
1989
298
0.010
Why?
Comeau's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_